lifestyle.capitolhilltimes.com

Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer

Written by

Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer – NEWSnet – News… as it used to be

More Press Releases

April 27, 2026

Lokal Media House Wins Web Excellence Award for Black Plumbing Redesign

April 27, 2026

Ever.Ag Unveils Everett, the Ag Decision Engine Built for the Agricultural Supply Chain

April 27, 2026

Nexans to acquire Republic Wire, establishing a strategic platform in the United States

April 27, 2026

Conduent to Report First-Quarter 2026 Financial Results on May 11, 2026